Target intelligence / Profile preview

Nourishing the liver

Molecular classification
Therapeutic Principle, Traditional Chinese Medicine Category
01

Overview

The term "Nourishing the liver" refers to a therapeutic principle or functional category of treatment rather than a discrete biological target like a receptor, enzyme, or transporter (World Health Organization International Standard Terminologies). Predominantly found in Traditional Chinese Medicine (TCM) and integrative hepatology, it describes a physiological objective aimed at protecting liver cells from damage, reducing oxidative stress, and promoting hepatic repair (National Center for Complementary and Integrative Health). Because it represents a broad clinical goal, it does not map to a single gene or protein structure; instead, it involves the modulation of diverse pathways such as the inflammatory cascade and metabolic homeostasis (PubMed, PMID: 31085160). Common substances associated with this concept include silymarin and various polyherbal formulations used to manage chronic liver diseases and fibrosis (NIH LiverTox). From a drug discovery perspective, this is a phenotypic description of hepatoprotection rather than a specific molecular target for rational drug design. Biotech analysts should view this as a therapeutic category or indication rather than a druggable protein.

Other names
Yang GanHepatic nourishmentLiver tonifyingHepatoprotective actionLiver-nourishing
02

Mechanism of action

As a therapeutic principle rather than a single molecule, it acts through multi-targeted pathways including the activation of the Nrf2 antioxidant pathway, inhibition of NF-kappaB-mediated inflammation, and stabilization of hepatocyte cell membranes.

03

Biological functions

HepatoprotectionOxidative stress reductionAnti-inflammatory responseHepatocyte regeneration
04

Disease associations

Chronic hepatitisLiver cirrhosisNon-alcoholic fatty liver disease (NAFLD)Hepatotoxicity
05

Safety considerations

Potential for herb-drug interactionsLack of molecular specificityQuality control issues in herbal productsRisk of idiosyncratic drug-induced liver injury (DILI) from complex formulations
06

Interacting drugs

Silymarin

4 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Gamma-glutamyl transferase (GGT)Total bilirubin

Beyond the preview

Go deeper on Nourishing the liver.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nourishing the liver.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call